UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 434

Sortiert nach

Pharmacological profile of sulodexide

International angiology, 2014-06, Vol.33 (3), p.229

2014

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris

The American journal of cardiology, 1999-12, Vol.84 (12), p.1391-1395

1999

Link zum Volltext

Verfügbarkeit prüfen

Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes

Clinical chemistry (Baltimore, Md.), 1998-08, Vol.44 (8), p.1845-1853

1998

Link zum Volltext

Verfügbarkeit prüfen

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

Expert opinion on investigational drugs, 2001-11, Vol.10 (11), p.1925-1935

2001

Link zum Volltext

Verfügbarkeit prüfen

Antithrombin agents as anticoagulants and antithrombotics : Implications in drug development

Seminars in hematology, 1999, Vol.36 (1), p.42-56

1999

Link zum Volltext

Verfügbarkeit prüfen

Successful Use of Recombinant Hirudin and Its Monitoring by Ecarin Clotting Time in Patients with Heparin-Induced Thrombocytopenia Undergoing Off-Pump Coronary Artery Revascularization

Journal of cardiac surgery, 2005-01, Vol.20 (1), p.42-51

2005

Link zum Volltext

Verfügbarkeit prüfen

Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. A randomised controlled trial

International angiology, 1996-06, Vol.15 (2), p.162

1996

Link zum Volltext

Verfügbarkeit prüfen

The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin

Blood coagulation & fibrinolysis, 1995-06, Vol.6 Sup 1 (Sup 1), p.S57-S64

1995

Link zum Volltext

Verfügbarkeit prüfen

Antithrombin and anti-Xa agents in the control of thrombogenesis

Pharmazie, 2001-10, Vol.56, p.S12-S21

2001

Link zum Volltext

Verfügbarkeit prüfen

Preclinical differentiation of low molecular weight heparins

Seminars in thrombosis and hemostasis, 1999, Vol.25, p.63-72

1999

Link zum Volltext

Verfügbarkeit prüfen

Comparative Tissue Factor Pathway Inhibitor Release Potential of Heparins

Clinical and applied thrombosis/hemostasis, 2005-01, Vol.11 (1), p.37-47

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of low molecular weight heparins in animal models

Seminars in thrombosis and hemostasis, 1999, Vol.25, p.51-55

1999

Link zum Volltext

Verfügbarkeit prüfen

TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin

Thrombosis research, 1995-01, Vol.77 (2), p.175-185

1995

Link zum Volltext

Verfügbarkeit prüfen

An Update on Heparins at the Beginning of the New Millennium

Seminars in thrombosis and hemostasis, 2000, Vol.26 (s1), p.005-022

2000

Link zum Volltext

Verfügbarkeit prüfen

Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs

Clinical chemistry (Baltimore, Md.), 1997-09, Vol.43 (9), p.1786-1788

1997

Link zum Volltext

Verfügbarkeit prüfen

Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia: Heparin-induced thrombocytopenia

Seminars in thrombosis and hemostasis, 1999, Vol.25, p.51-56

1999

Link zum Volltext

Verfügbarkeit prüfen

A consensus conference on complex biologics and low molecular weight heparins

International angiology, 2010-04, Vol.29 (2), p.193

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of Different Anticoagulant Agents on Fibrinopeptide A Generation

Clinical and Applied Thrombosis/Hemostasis, 2003-10, Vol.9 (4), p.273-292

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using high performance liquid chromatography and functional methods

International angiology, 1999-09, Vol.18 (3), p.198

1999

Link zum Volltext

Verfügbarkeit prüfen

A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans

Blood coagulation & fibrinolysis, 1998-09, Vol.9 (6), p.517-524

1998

Link zum Volltext

Verfügbarkeit prüfen

Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development

The Medical clinics of North America, 1998-05, Vol.82 (3), p.569-586

1998

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of argatroban in primates: evidence on endogenous uptake

International angiology, 2000-06, Vol.19 (2), p.126

2000

Link zum Volltext

Verfügbarkeit prüfen

Laboratory Monitoring of Pentasaccharide in a Dog Model of Hemodialysis

Thrombosis research, 1999-10, Vol.96 (2), p.115-124

1999

Link zum Volltext

Verfügbarkeit prüfen

Current perspectives on low molecular weight heparins

Seminars in thrombosis and hemostasis, 1993, Vol.19, p.1-11

1993

Link zum Volltext

Verfügbarkeit prüfen

Acquired Defects of Fibrinolysis Associated with Thrombosis

Seminars in thrombosis and hemostasis, 1999-01, Vol.25 (4), p.367-374

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 434

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(411)
Mit Volltextzugriff
(390)

Publikationsform

Sprache

Englisch
(434)
Japanisch
(31)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(247)
Humans
(197)
Cardiovascular System & Cardiology
(191)
Hematology
(191)
Peripheral Vascular Disease
(181)
Biological And Medical Sciences
(132)
Medical Sciences
(125)
Pharmacology. Drug Treatments
(97)
Animals
(87)
Male
(87)
Blood. Blood Coagulation. Reticuloendothelial System
(83)
Female
(69)
Heparin - Pharmacology
(46)
Anticoagulants - Pharmacology
(45)
Anticoagulants
(40)
Middle Aged
(40)
Adult
(38)
Anticoagulants - Therapeutic Use
(35)
Heparin, Low-Molecular-Weight - Pharmacology
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacological profile of sulodexide

Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris

Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

Antithrombin agents as anticoagulants and antithrombotics : Implications in drug development

Successful Use of Recombinant Hirudin and Its Monitoring by Ecarin Clotting Time in Patients with Heparin-Induced Thrombocytopenia Undergoing Off-Pump Coronary Artery Revascularization

Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. A randomised controlled trial

The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin

Antithrombin and anti-Xa agents in the control of thrombogenesis

Preclinical differentiation of low molecular weight heparins

Comparative Tissue Factor Pathway Inhibitor Release Potential of Heparins

Pharmacokinetics of low molecular weight heparins in animal models

TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin

An Update on Heparins at the Beginning of the New Millennium

Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs

Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia: Heparin-induced thrombocytopenia

A consensus conference on complex biologics and low molecular weight heparins

Influence of Different Anticoagulant Agents on Fibrinopeptide A Generation

Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using high performance liquid chromatography and functional methods

A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans

Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development

Pharmacokinetics of argatroban in primates: evidence on endogenous uptake

Laboratory Monitoring of Pentasaccharide in a Dog Model of Hemodialysis

Current perspectives on low molecular weight heparins

Acquired Defects of Fibrinolysis Associated with Thrombosis

Suchergebnisse filtern